Novo Holdings A/S’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Novo Holdings A/S’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-118,441	Closed	-$3.52M	–	53
2021 Q4	$3.52M	Sell	118,441 -10,103	-8%	-$413K	0.17%	48
2021 Q3	$6.58M	Sell	128,544 -28,871	-18%	-$2.05M	0.34%	39
2021 Q2	$19.2M	Hold	157,415	–	–	0.85%	26
2021 Q1	$29M	Hold	157,415	–	–	1.2%	19
2020 Q4	$43.1M	Buy	157,415 +113,082	+255%	+$28.4M	1.85%	14
2020 Q3	$10.4M	Buy	+44,333	New	+$11.1M	0.52%	29

Other funds holding FRLN

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Novo Holdings A/S's FRLN Position: Q1 2022 in Review

Novo Holdings A/S sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2022, closing a stake of 118,441 shares — an estimated $3.52M sold.

Novo Holdings A/S first reported a position in FRLN in Q3 2020 and held it in 6 quarters. The position peaked at $43.1M in Q4 2020. 19 funds tracked by Wall St. Rank hold FRLN as of Q1 2022.

Novo Holdings A/S reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Novo Holdings A/S sold 118,441 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2022, an estimated $3.52M.
Novo Holdings A/S first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 6 quarters.
Novo Holdings A/S's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $43.1M in Q4 2020.
19 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2022.

Based on Novo Holdings A/S's 13F filing for Q1 2022, filed 16 May 2022.